Project Scope

To understand the healthcare policies and potential access, reimbursement, funding opportunities for DLBCL CAR-T therapies in KSA

Challenge

Our client is a leading provider of targeted therapies for treatment of rare diseases. They wanted to understand the evolving healthcare policies, potential access and funding opportunities in private and public sector for CAR-T therapies in KSA

Solution

Conducted extensive primary research to get detailed insights on:

• Pricing and reimbursement process for high cost therapies in public and private sector
• National and hospital level and alternative funding pathways feasible for DLBCL CAR-T therapies
• Changes in healthcare policies in future impacting public funding for CAR-T in future

Results

• Enabled our client to understand local funding and access pathways for high cost therapies
• Recommended approaches from payer viewpoint to secure funding for high cost therapies in both private and public sector